These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 9449012)
1. Peripheral cocaine-blocking agents: new medications for cocaine dependence. An introduction to immunological and enzymatic approaches to treating cocaine dependence reported by Fox, Gorelick and Cohen in the immediately succeeding articles (see pages 153-174). Sparenborg S; Vocci F; Zukin S Drug Alcohol Depend; 1997 Dec; 48(3):149-51. PubMed ID: 9449012 [No Abstract] [Full Text] [Related]
2. Development of a therapeutic vaccine for the treatment of cocaine addiction. Fox BS Drug Alcohol Depend; 1997 Dec; 48(3):153-8. PubMed ID: 9449013 [TBL] [Abstract][Full Text] [Related]
3. Ethical issues in using a cocaine vaccine to treat and prevent cocaine abuse and dependence. Hall W; Carter L J Med Ethics; 2004 Aug; 30(4):337-40. PubMed ID: 15289512 [TBL] [Abstract][Full Text] [Related]
4. Anti-cocaine vaccine based on coupling a cocaine analog to a disrupted adenovirus. Koob G; Hicks MJ; Wee S; Rosenberg JB; De BP; Kaminsky SM; Moreno A; Janda KD; Crystal RG CNS Neurol Disord Drug Targets; 2011 Dec; 10(8):899-904. PubMed ID: 22229312 [TBL] [Abstract][Full Text] [Related]
5. Structure-and-mechanism-based design and discovery of therapeutics for cocaine overdose and addiction. Zheng F; Zhan CG Org Biomol Chem; 2008 Mar; 6(5):836-43. PubMed ID: 18292872 [TBL] [Abstract][Full Text] [Related]
6. The future potential for cocaine vaccines. Orson FM; Wang R; Brimijoin S; Kinsey BM; Singh RA; Ramakrishnan M; Wang HY; Kosten TR Expert Opin Biol Ther; 2014 Sep; 14(9):1271-83. PubMed ID: 24835496 [TBL] [Abstract][Full Text] [Related]
7. Anticocaine catalytic antibodies have no affinity for RTI compounds: implications for treatment. Kuhar MJ; Carroll FI; Bharat N; Landry DW Synapse; 2001 Aug; 41(2):176-8. PubMed ID: 11400184 [TBL] [Abstract][Full Text] [Related]
9. Cocaine catalytic antibodies: the primary importance of linker effects. Matsushita M; Hoffman TZ; Ashley JA; Zhou B; Wirsching P; Janda KD Bioorg Med Chem Lett; 2001 Jan; 11(2):87-90. PubMed ID: 11206477 [TBL] [Abstract][Full Text] [Related]
10. Enhancing cocaine metabolism with butyrylcholinesterase as a treatment strategy. Gorelick DA Drug Alcohol Depend; 1997 Dec; 48(3):159-65. PubMed ID: 9449014 [TBL] [Abstract][Full Text] [Related]
11. Lamotrigine reduces craving and depressive symptoms in cocaine dependence. Pavlovic Z J Neuropsychiatry Clin Neurosci; 2011; 23(1):E32. PubMed ID: 21304126 [No Abstract] [Full Text] [Related]
15. Time course of changes in cocaine self-administration behavior in rats during immunization with the cocaine vaccine IPC-1010. Kantak KM; Collins SL; Bond J; Fox BS Psychopharmacology (Berl); 2001 Jan; 153(3):334-40. PubMed ID: 11271406 [TBL] [Abstract][Full Text] [Related]
16. A double-blind, placebo-controlled outpatient trial of pergolide for cocaine dependence. Malcolm R; Kajdasz DK; Herron J; Anton RF; Brady KT Drug Alcohol Depend; 2000 Aug; 60(2):161-8. PubMed ID: 10940543 [TBL] [Abstract][Full Text] [Related]
18. Risperidone diminishes cue-elicited craving in withdrawn cocaine-dependent patients. Smelson DA; Roy A; Roy M Can J Psychiatry; 1997 Nov; 42(9):984. PubMed ID: 9429074 [No Abstract] [Full Text] [Related]